Original Research

Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer

Ouyang XP, Huang Y, Jin X, Zhao W, Hu T, Wu F, Huang J

OncoTargets and Therapy 2018, 11:5933-5941

Published Date: 19 September 2018